Agenda

Displaying agenda in the event’s time zone (EDT, UTC -4)

MASTERCLASSES
Tuesday, September 20, 2022
CONFERENCE DAY 1
Wednesday, September 21, 2022
CONFERENCE DAY 2
Thursday, September 22, 2022

Registration and Networking Breakfast

Creating and Delivering Reports that Make a Difference

Impacting major decisions with information, insight, and context is not easy.

The Molekule team will highlight the key considerations in developing an impactful, strategic, delivery that considers the type of decision being influenced, the audience, the purpose, and destroys some of the widely held myths about report writing and presenting. Dave Alderman, Founder and President, and Chris Stevenson, Managing Director, Europe

Presented by Molekule Consulting

Refreshment Break

How to Create a Winning Competitive Landscape Analysis – A Step-by-Step Practical Guide

An interactive session where the Lifescience Dynamics team will share its knowledge and experience in building and analysing a comprehensive landscape.

o Steps for understanding a new therapy area
o Identification of key players in the space, from preclinical through to marketed products
o Predicting competitors’ timelines by preparing well supported assumptions using CI Insights

Presented by Lifescience Dynamics

Networking Lunch

Developing a Competitive Activity Framework to Enhance Organizational Competitiveness

This workshop session will give participants first-hand insights from a combined 30+ years of experience in delivering strategic and tactical workshop-style solutions, using an optimal blend of established CI frameworks alongside INOVIS’ in-house proprietary methodologies.

Key to this session will be addressing business needs across the lifecycle, whereby participants will:

* Develop an in-depth understanding of how a diverse range of facilitated activities (Rapid Immersion, Threat Assessment and Competitor Simulations) can help deliver strategic and competitive insights within an organization
* Appreciate the importance of leveraging the outcomes of workshops to inform and direct decision making
* Receive hands-on opportunities to apply learnings to a pharma case-study in a learning environment
Using business case studies, real-life experiences and validated theory, the INOVIS team will equip you with a number of go-to techniques that can be rapidly integrated into ongoing CI Practice, whether you’re a seasoned CI professional veteran, or newer to the field.

Presented by INOVIS

Refreshment Break

Blockbuster Competitive Intelligence: Building a Winning Strategy!

A prescription drug that surpasses $1 billion in sales is known as a blockbuster. It is a rare feat, but when a pharmaceutical company has the opportunity to build a blockbuster drug they usually have a robust competitive readiness program in place.

Blockbuster Competitive Intelligence is a new framework that almost nobody knows. This framework maximizes the potential of a drug and increases the impact that you can have with competitive intelligence.

So, what is it and how can you leverage it?

Blockbuster Competitive Intelligence outlines how Competitive Intelligence is used to develop, launch, and commercialize a blockbuster drug (or a drug that is critical to the success of the organization).

Over the past two decades, we have worked with multiple blockbusters and potential blockbuster products. We have experimented and innovated successful approaches while working at Roche, Novartis. With Atacana we continue to innovate and support the majority of the top 10 pharma companies helping their blockbuster competitive intelligence strategies.

In this interactive workshop, we will share with you our Blockbuster Competitive Intelligence framework and learn from other participants what it takes to develop a winning strategy.

Our goal is to help you maximize the potential of your product and maximize your potential for you next career move!

We look forward to seeing you there!

Presented by Atacana Group

Masterclasses Conclude

Registration & Networking Breakfast in Exhibition Hall

Chairperson’s Opening Remarks

Presented by Johnson & Johnson

Keynote: The Changing Landscape of Healthcare

Steve Andrzejewski, Adjunct Professor, Health Economics, NYU Stern School of Business
Healthcare is complex, represents 20% of the U.S. GDP and is changing all the time. New partnerships and models are evolving - how will the pharmaceutical industry participate moving forward.

Presented by NYU Stern School of Business

How to Build a Successful and Sustainable CI Function

When structuring an in-house CI function there are several critical considerations.

The Molekule team will challenge the audience to think differently about the purpose and role of the CI function and explain from experience how to create an influential, integrated function that is respected and integral to decision making. It has a lot to do with purpose and position. For those who already lead in-house teams this presentation will challenge your role and goals and make you think differently about how your function is positioned.

Presented by Molekule Consulting

Refresh and Connect in Exhibition Hall

Leveraging CI to Shape Your Real World Evidence Strategy: Case Studies on the Power of CI and Its Benefits for RWE

Lifescience Dynamics will discuss how competitive intelligence can be used to inform and develop a successful real world evidence strategy

• Understand the interlink between RWE and CI – RWE to inform strategies and CI to drive RWE approaches
• Benchmark competitors’ RWE strategies
• Develop RWE-driven go-to-market, market access and life cycle management strategies

Presented by Lifescience Dynamics

Keynote: Executive Level Boardroom Discussions

Presented by Abbott, Abbvie, Biomarin, Boehringer Ingelheim, Johnson & Johnson, and Novartis

“Ask the Experts” Interactive Breakout Groups

(Explore and capture the power of participants’ Insights and experiences and exploration of these topics in this fun and informal environment in small groups.)
BREAKOUT 1
Mentor/Mentee What is Needed for a Good Relationship!

Presented by Novocure and PTC Therapeutics

BREAKOUT 2
Competitive Intelligence and Biopharma Manufacturing

• Sources, methods, and outputs of manufacturing intelligence collection

• Captive versus outsourced development and manufacturing models
• CI’s role and contribution to S&OP and commercialization
• Integrating manufacturing intel into current CI programs

Presented by ThermoFisher Scientific

BREAKOUT 3
Role of CI in Partnering and Strategic Initiatives

Presented by Horizon

BREAKOUT 4
Measuring the Value of Competitive Intelligence

Presented by Viridian Therapeutics

BREAKOUT 5
Early Stage Pipeline

Presented by Abbvie

BREAKOUT 6
CI Work with Alliance: Dos, Don’ts and Considerations for Biopharma Professionals Working in Alliance Partnerships

Presented by Karyopharm Therapeutics

Networking Luncheon

Leadership Insight: Case Studies

SESSION ONE

Communicating to Senior Execs and Impacting Strategy to Drive Key Business Decisions

Presented by Vir Biotechnology

SESSION TWO

Role of CI in Partnering and Strategic Initiatives

Presented by GlaxoSmithKline

SESSION THREE

How to use Competitive Intelligence to Influence Decisions and Drive Impact

Presented by Ionis Pharmaceuticals

Think Labs: Innovation

SESSION ONE

Using Competitive Dashboards to Stay Ahead of Your Competition: Realistic Considerations for an Online Tool

• Sensitivity vs Specificity - Finding the right balance

• 3rd party integration
• Housing and indexing internal files
• Walkthrough of ProactivePulse

Presented by Proactive Worldwide

SESSION TWO

The Journey of Artificial Intelligence and Machine Learnings in Supporting & Informing Business Strategy - Case Studies and Learnings

Today more than ever, we are flooded with more information on a daily basis than we can consume.

We need new tools now to help us sort, distill, categorize, and prioritize the events around us to deliver the insights that our business partners depend on. Most of our success in this effort has been through integrating in various combinations our own proprietary libraries with the powerful NLP, NER, and neural network tools. Please join us as we review our learnings and applications of these to real life business case studies.

Presented by Ozmosi

SESSION THREE

Get Ready to SPRING Forward

On top of facilitating your Competitive Intelligence (secondary and primary), GlobalReach BI has implemented a Knowledge Management platform: SPRING...

Using the power of the latest technology, SPRING consolidates all your intelligence around a topic, disease area, mechanism of action, competitor, in a structured manner. Your internal teams can have access to allow fast & easy searching to connect all the dots across your clinical & commercial intelligence, across your organization.

SPRING uses transcription technology to make sure all your insights are integrated into your dedicated platform. Let’s take a look at how AI can benefit you in your CI workflow and most importantly, tremendously increase your CI efficiency.

Presented by GlobalReach BI

Best Practices and Insights

SESSION ONE

Leverage CI to Bring Speed, Accuracy, and Efficiency to Omnichannel & Digital Launch Strategy

AdametNext in collaboration with The STEM, an award-winning customer engagement and digital transformation consultancy, will present a unique viewpoint and a tested framework on using CI for highly efficient Omnichannel & Digital launches.

Presented by AdametNext

SESSION TWO

Maximize your Learnings from Presenters and When you Visit Booths at Medical Conferences/Congresses

Presented by inPhronesis and inThought

SESSION THREE

Digital Transformation of “News Alerts” to Enable Faster and Better Decision-Making

Daily monitoring across competitors, products and indications is one of the major effort driver for all Pharma companies.

While there are automated tools to collect and source news feeds- analysis, curation and distribution of competitive insights still remains a huge challenge. This session’s goal is to share how digital technologies can help in creating a single, unified productivity and workflow platform to collect, curate, and deliver intel/alerts to enable better and faster decision-making across the organization.

Presented by DataZymes

Refuel & Rejuvenate in Exhibition Hall

Think Tanks: Learning Environment

SESSION ONE

How To Reboot Competitive Intelligence Framework Across Healthcare Ecosystem, Focused On Entire Spectrum Of Stakeholder Insights

This session is intended for healthcare industry stakeholders who will be benefit by

1. Understanding of Integrated CI methodology across healthcare ecosystem which provides 360-degree insights
2. Development of stronger CI and BI insights roadmap and intuitive visualization for CI end users
3. Empower CI end users with real-time data reporting and analytics topped with social media and web insights

Presented by Borderless Access

SESSION TWO

How has Brexit Altered the New Medicines' Regulatory Landscape in Europe?

Brexit; a seismic shift in the European regulatory landscape, or not? Since the 1st of January 2021, the UK no longer automatically follows the EMA decisions for new medicine approvals.

What does this mean for pharmaceutical companies applying for marketing authorisation in the EU and the UK?

Dig Worldwide will guide attendees through a map of this altered territory for medicine approvals in the EU and the UK, with key dates along assessment timelines. You will learn the procedural options available, how fast your clients’ competitors could reach market depending on the pathway to approval they choose, and what all this could mean for UK Pharma.

Presented by Dig Worldwide

SESSION THREE

How to Become a Pharma CI Transformer: Interpreting an IDC Multi-Client Study

IDC calls the most sophisticated knowledge management (KM) user organizations transformers; they cut across industries and use cases.

How do their systems and practices relate specifically to the competitive intelligence function at leading pharma companies? In this webinar we’ll draw on IDC’s recent research findings on “intelligent knowledge networks” to offer insights into:

What capabilities and best practices make an organization a “transformer” in the competitive intelligence space; and
How being an advanced KM user benefits business decision-making and decision-makers in the pharma industry

Presented by Northern Light

Engage in High Level Debate and Discussion

SESSION ONE

Role of CI in BD Due Diligence

Presented by AbbVie, ADC Therapeutics, Amicus Therapeutics, Gilead Sciences, and Viridian Therapeutics

SESSION TWO

Insights into New Product Planning and Decision Making

Presented by Concarlo Therapeutics, Ferring Pharmaceuticals, Ionis Pharmaceuticals, Myovant Sciences, and Roche Diagnostics

Drink, Eat & Be Merry! Outside (weather permitting) Reception & Networking

Registration & Networking Breakfast in Exhibition Hall

Leadership Insight: Case Studies

SESSION ONE

Moving the Needle in Pharma/CI Collaborations

Discuss most common issues impacting CI collaborations and projects between pharma manufacturers and CI companies and ways to address them.

Presented by AbbVie and Eisai

SESSION TWO

Small Budget, Big Insights

• Leveraging what you can get now and asking yourself (and others) what would you do differently with that information.

• Focus groups and conferences, what, how, where, when and who.
• Transforming how an organization makes decisions (case study)

Presented by MiMedx

SESSION THREE

CAR-T Cell Therapy Market

Primer plus how to cover cell therapy because of its vastness, volume of unknowns and also evolving needs of the company

Presented by Atara Biotherapeutics

Idea Labs: Gain New Perspectives

SESSION ONE

Strategic Competitor Profile Dashboard: Empowering Cross-Functional Expert Teams to Make the Most of Their Data

• A case study on how best to streamline diverse CI datasets using intelligence-based visualizations to inform strategic and tactical decisions

• Practical thoughts will be discussed on the key factors to consider when designing and implementing innovative tool-based data analytics solutions focusing upon discrete competitive landscapes

Presented by Lifescience Dynamics and Bristol Myers Squibb

SESSION TWO

Combining Public Data Curation, Digitization, and Social Listening for Better CI in Oncology

There is a vast and ever-growing amount of public data in the oncology space from publications and press releases to conference disclosures and other sources.

This data is spread across a variety of disparate sources making comparisons and actionable insights cumbersome. With the CLIN cancer trial results platform, our team is combining text mining and curation to put all the data into a common, searchable model. To further enhance insights through this platform, we are also digitizing outcomes data to enable quick meta-analyses and using social listening to give users a view of how digital opinion leaders are reacting to new data releases.

Presented by LARVOL

SESSION THREE

Using Primary and Secondary Insights to Optimize Global Pharmaceutical Sales Force Strategies 2.0

Prior to 2020, the pharmaceutical field forces were geared towards in-person interactions and information exchange.

That all changed when the COVID-19 pandemic forced many medical offices to restrict visitors and pharmaceutical sales reps. A lasting impact has been a re-focusing of the sales rep role and a restructuring of the sales structure.

This session will explore how pharmaceutical sales evolved in the COVID-19 era and how that evolution will continue in the post-COVID era. The impacts include changes in how salespeople interact with the medical community, the role of technology in the sales program, and how sales will integrate with other commercial and medical support resources.

It is very likely that there will be continued changes in the sales force over the next few years as the early adaptions to COVID restrictions are refined and made permanent. In this session, some of the change drivers and how they will be implemented will be debated. If you are concerned about where your field force, or your competitors’, is going, it is a can’t miss session.

Presented by Fletcher/CSI

Innovation and Digital Transformation

SESSION ONE

Impact of Artificial Intelligence on Pharma CI

Case Study: Learn how Pfizer used AI to cut costs by 50% & enabled teams to focus on higher-order thinking.

Presented by ZoomRx

SESSION TWO

Strategic Insights to Influence Medical and Commercial Planning

From designing your clinical development strategy to optimizing your commercial planning, having the necessary forward-looking insight is key to confident cross-functional decision making.

No longer can competitor, market and stakeholder intelligence be delivered on an ad hoc basis in a format that is difficult to decipher; decision-makers require dynamic, targeted, high-impact insight that provides clarity and empowers them to act in a timely manner.

Presented by Prescient

SESSION THREE

See the Full Picture: Layering Market Access Intelligence over Standard Competitive Intelligence Offerings

With the 2018 FDA guidance for drug and device manufacturers regarding communications with payors and the Pre-approval Information Exchange (PIE) Act of 2022, market access intelligence has become an increasingly important element in assessing competitors.

The clinical and commercial aspects of traditional competitive intelligence are enhanced with the addition of HEOR messaging, field-based reimbursement teams, directional contracting and marketing strategies. This session will review FADAMA 114 and the PIE Act and provide examples of market access intelligence including, rebating/contracting, value-based agreements, adherence-based contracts, pay for performance contracts and various hybrid reimbursement models. Please join us for an informative presentation to help you see the full picture to inform your strategy.

Presented by Healthcare Intelligence and Analytics

Refresh and Connect in Exhibition Hall

“Ask the Experts” Interactive Breakout Groups

(Explore and capture the power of participants’ Insights and experiences and exploration of these topics in this fun and informal environment in small groups.)
BREAKOUT 1
Competitive Intelligence and Biopharma Manufacturing

• Sources, methods, and outputs of manufacturing intelligence collection

• Captive versus outsourced development and manufacturing models
• CI’s role and contribution to S&OP and commercialization
• Integrating manufacturing intel into current CI programs

Presented by ThermoFisher Scientific

BREAKOUT 2
Role of CI in Partnering and Strategic Initiatives

Presented by Horizon

BREAKOUT 3
CI Work with Alliance: Dos, Don’ts and Considerations for Biopharma Professionals Working in Alliance Partnerships

Presented by Karyopharm Therapeutics

BREAKOUT 4
Measuring the Value of Competitive Intelligence

Presented by Viridian Therapeutics

BREAKOUT 5
Early Stage Pipeline

Presented by Abbvie

Networking Luncheon

Announcement of Raffle Prize Winners

Generics & Biosimilars – Important Learnings from Real World Case Studies

This session highlights innovative approaches leveraged by generic and biosimilars to speed up market entry. Specifically, this presentation will enable you to:

• Advance your understanding of core regulatory routes, timelines and strategies
• Understand core Gx/biosimilar product development and entry strategies
• Learn from & set up a best-in-industry Gx/biosimilar regulatory intelligence (RI) and CI tracking program
The presentation will be supported by thought provoking real-world case studies to stress differences between theory vs actual approaches

Presented by INOVIS

Strategic Decision Making: Turning Insights into Actions

The aim of competitive intelligence is to help Pharma Leaders to develop a winning strategy. The traditional CI model of gathering intelligence and generating insights is not enough.

Developing, launching and growing blockbuster brands require a well defined strategic decision making process.

In this presentation, we will share our proven 3 step process needed to identify your key competitors, assess several credible scenarios, and identify the key success factors, risks and concrete actions to execute your winning strategy.

The presentation incorporates learnings from leading the CI functions at Roche and Novartis, supporting the majority of Big Pharma companies CI efforts, and the latest management thinking from Harvard Business School.

We look forward to seeing you there!

Presented by Atacana Group

Macro Trends in Pharma and Their Impact within Competitive Intelligence

Presented by AbbVie, Bristol Myers Squibb, Gilead Sciences, and Pfizer

Closing Remarks

Presented by Abbott, Bayer, Biomarin, Boehringer Ingelheim, Eli Lilly, Johnson & Johnson, and Novartis

Conference Concludes

“COVID-conscious” Guidelines Distributed in Detail On-site but Includes:

• Use of masks required: Please bring your own if preferred, but masks and hand sanitizer will also be provided.
• Greetings should be socially distanced: no handshakes, hugs, or kisses, etc.
• Meeting space will accommodate more spacing between attendees.
• The hotel experience will be entirely revamped with specific cleaning protocols.

error: Content is protected !!